ACR asks for your vote

Clint vanSonnenberg | | Health Imaging | Oncology Imaging
The American Medical Association (AMA) is holding a vote to distribute seats between medical specialties within the organization’s House of Delegates, and the American College of Radiology (ACR) is pushing its members to vote for the ACR to represent the interests of radiology and its subspecialties.

According to the ACR, a vote for the organization is supported by the Radiologic Society of North America (RSNA), the American Roentgen Ray Society (ARRS), the American Society for Therapeutic Radiology and Oncology (ASTRO), the Societies of Interventional Radiology (SIR) and Nuclear Medicine (SNM) and other specialty organizations. Delegates from these societies, along with the ACR, constitute the AMA Section Council on Radiology.

One delegate in the House is allotted for every 1,000 votes for a particular society. AMA members can vote by calling 1-800-621-8335, or by clicking here.

Clint vanSonnenberg

Related Content

New radiopharmaceutical targeted at gastrointenstinal cancers yields impressive results
New PET method combines antibody with radioactive isotope to improve lung cancer detection
VI-RADS threshold, imaging features predict bladder cancer invasiveness with nearly 100% accuracy
PHOTO GALLERY: thyroid nodule imaging
Tiny 'water bears' may hold key to reducing radiation-induced side effects
High-intensity focused ultrasound could allow prostate cancer patients to avoid surgery

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.